Valuation ranges for medical weight loss clinics span 3.5x–6x EBITDA. Patient retention, GLP-1 compliance, and provider diversification are the biggest value drivers.
Medical weight loss clinics in the $1M–$5M revenue range typically trade at 3.5x–6x EBITDA, depending on recurring revenue quality, provider structure, and regulatory standing. The GLP-1 boom has elevated buyer interest significantly, but acquirers — including PE-backed rollups and physician entrepreneurs — apply heavy scrutiny to churn rates, prescribing compliance, and key-person risk before committing to premium multiples.
| Business Tier | EBITDA Range | Multiple Range | Notes |
|---|---|---|---|
| Distressed or High-Risk | $150K–$300K | 2.5x–3.5x | Single-provider dependency, high patient churn, inconsistent financials, or unresolved compliance issues. Limited buyer pool; SBA financing unlikely. |
| Average Owner-Operated Clinic | $300K–$500K | 3.5x–4.5x | Stable enrollment, cash-pay revenue, owner-physician transition risk present. SBA 7(a) eligible with seller note component typical. |
| Strong Recurring Revenue Model | $500K–$800K | 4.5x–5.5x | Membership-based revenue, multiple credentialed providers, clean compliance history, and documented GLP-1 protocols drive premium positioning. |
| Platform-Ready Multi-Location | $800K+ | 5.5x–6x+ | Scalable systems, employer contracts, minimal key-person risk. Attractive to PE rollups; equity recapitalization structures common. |
Patient Retention & Recurring Revenue
High impactMembership or program-based models with low 90-day dropout rates command significant premium. Cohort data showing 12–24 month average patient tenure is a top buyer priority.
Provider Diversification
High impactClinics with multiple credentialed providers beyond the owner-physician reduce key-person risk and protect licensure continuity, directly supporting higher multiples.
GLP-1 Compliance & Prescribing Protocols
High impactDocumented, defensible prescribing practices, DEA registration currency, and clean state medical board history are prerequisites for premium valuations and SBA eligibility.
Payer Mix & Revenue Quality
Medium impactCash-pay and employer-contract revenue is valued more highly than insurance-dependent income due to faster collections, higher margins, and lower administrative complexity.
Brand & Patient Acquisition Systems
Medium impactStrong local SEO, PCP referral networks, or employer wellness contracts reduce patient acquisition costs and demonstrate scalable growth potential attractive to rollup buyers.
PE-backed healthcare platforms accelerated weight loss clinic acquisitions in 2023–2024, compressing cap rates and pushing quality assets toward the 5x–6x range. Simultaneously, national telehealth GLP-1 competitors commoditized standalone prescription services, penalizing single-service clinics. Compounded semaglutide regulatory uncertainty in 2024 added a new due diligence layer around medication sourcing and protocol documentation.
Single-location cash-pay clinic, 600 active patients, owner-physician transitioning, GLP-1 and nutrition program, Southeast market
$380K
EBITDA
3.8x
Multiple
$1.44M
Price
Two-location medical weight loss center, membership model, two NPs plus medical director, strong retention metrics, Midwest
$620K
EBITDA
5.2x
Multiple
$3.22M
Price
Multi-service clinic with employer wellness contracts, ancillary body composition services, scalable protocols, PE acquisition target
$950K
EBITDA
5.8x
Multiple
$5.51M
Price
EBITDA Valuation Estimator
Get your Weight Loss Clinic business value range instantly
Industry: Weight Loss Clinic · Multiples based on 3.5x–4.5x (Average Owner-Operated Clinic)
Powered by Deal Flow OS
dealflow-os.com · Free M&A tools for every stage of the deal
Most clinics sell at 3.5x–6x EBITDA. Quality of recurring revenue, provider structure, and GLP-1 compliance are the primary factors determining where you fall in that range.
It can do both. Documented, compliant GLP-1 programs with strong retention boost value. Clinics dependent solely on compounded semaglutide without diversified services face buyer skepticism and valuation discounts.
Yes, SBA 7(a) loans are commonly used for weight loss clinic acquisitions, typically covering 80–90% of the purchase price. Clean licensing, positive cash flow, and a manageable seller transition period are required.
Heavy owner dependency is the most common value killer. Buyers discount or add earnouts when one physician drives revenue. Transitioning clinical responsibilities to additional providers before sale meaningfully improves your multiple.
More Weight Loss Clinic Guides
DealFlow OS surfaces acquisition targets with seller signals and outreach angles. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers